SCHEMBL18398397

SCHEMBL18398397

CCc1cc(C#N)cc(F)c1Nc1cc2c(ncn2C)c(N)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 8/20 0.49
▸ JAK1 P23458 8/20 0.49
▸ TYK2 P29597 8/20 0.49
▸ JAK3 P52333 8/20 0.49
▸ CTSS P25774 4/20 0.32
▸ CTSK P43235 4/20 0.32
▸ CTSV O60911 1/20 0.31
▸ CTSL P07711 1/20 0.31
▸ CTSB P07858 1/20 0.31
▸ CTSH P09668 1/20 0.31
▸ CASP4 P49662 1/20 0.31
▸ MMP14 P50281 1/20 0.31
▸ CTSC P53634 1/20 0.31
▸ BACE1 P56817 1/20 0.31
▸ ADAM17 P78536 1/20 0.31
▸ CTSZ Q9UBR2 1/20 0.31
▸ KLK4 Q9Y5K2 1/20 0.31
▸ ABCB11 O95342 1/20 0.30
▸ NQO2 P16083 1/20 0.30
▸ MAP2K2 P36507 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398396 0.87 JAK1 (0.44) JAK2JAK1TYK2JAK3CTSS
SCHEMBL18398421 0.86 JAK2 (0.35) JAK2JAK1TYK2JAK3ABCB11
SCHEMBL18398568 0.86 JAK2 (0.39) JAK2JAK1TYK2JAK3MAP2K2
SCHEMBL18409286 0.84 JAK2 (0.47) JAK2JAK1TYK2JAK3CTSS
SCHEMBL16923302 0.83 JAK2 (0.45) JAK2JAK1TYK2JAK3CTSS
SCHEMBL18398275 0.81 JAK2 (0.39) JAK2JAK1TYK2JAK3CTSS
SCHEMBL15184329 0.81 JAK2 (0.43) JAK2JAK1TYK2JAK3MAP2K1
SCHEMBL18409285 0.80 TYK2 (0.62) JAK2JAK1TYK2JAK3
SCHEMBL18398229 0.78 JAK2 (0.51) JAK2JAK1TYK2JAK3CTSS
SCHEMBL18398169 0.78 JAK2 (0.62) JAK2JAK1TYK2JAK3CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback